Alon Altschuler is an Associate at aMoon Growth, where he drives due diligence processes in late-stage healthcare companies, including validating business models, company projections and assessing product market fit.
Growing up in a family of scientists and innovators, Alon has always been fascinated by the convergence of healthcare and finance and joined aMoon to merge these two passions. Alon joined the late-stage team after a formative period in our early-stage fund and brings with him a unique perspective in assessing future trends in early-stage disruptive technologies in HealthTech. Prior to joining aMoon, Alon worked as an Investment Banker at Citi, advising on M&A and capital markets transactions across a variety of sectors. Key deal experiences include: the acquisition of Bezeq, Israel’s telecom incumbent, by Searchlight Capital; and Teva Pharmaceutical’s $4.5B bond issuance. Alon worked as a Financial Consultant at Cognum (formerly Itzhak Swary & Co.), where he provided financial advisory services to corporate clients.
Alon holds a BA in Economics and Accounting (Magna Cum Laude) from the Hebrew University of Jerusalem.